| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
291,844,000 | 291,624,000 | 300,004,000 | 301,965,000 | 279,037,000 |
| Cost of Revenue
|
-119,232,000 | -121,881,000 | -128,977,000 | -123,256,000 | -112,950,000 |
|
Gross Profit
|
172,612,000 | 169,743,000 | 171,027,000 | 178,709,000 | 166,087,000 |
|
Selling, General and Administrative Expenses
|
-91,746,000 | -89,570,000 | -87,967,000 | -91,529,000 | -96,257,000 |
|
Research and Development Expenses
|
-26,226,000 | -26,185,000 | -24,103,000 | -25,416,000 | -28,297,000 |
| Depreciation, Amortization and Depletion
|
-8,894,000 | -8,773,000 | -8,812,000 | -9,471,000 | -9,518,000 |
| Other Income/Expense, Operating
|
2,596,000 | 2,583,000 | -3,265,000 | -13,753,000 | -35,105,000 |
|
Operating Income/Expenses
|
-124,270,000 | -121,945,000 | -124,147,000 | -140,169,000 | -169,177,000 |
|
Total Operating Profit/Loss
|
48,342,000 | 47,798,000 | 46,880,000 | 38,540,000 | -3,090,000 |
| Total Net Finance Income/Expense
|
-14,000 | -355,000 | 1,286,000 | -1,092,000 | -346,000 |
| Net Investment Income
|
-685,000 | -- | -685,000 | -7,575,000 | -2,362,000 |
|
Non-Operating Income/Expenses, Total
|
-14,000 | -355,000 | 601,000 | -8,667,000 | -2,708,000 |
|
Pretax Income
|
48,327,000 | 47,442,000 | 47,481,000 | 29,874,000 | -5,799,000 |
|
Provision for Income Tax
|
-9,429,000 | -9,881,000 | -11,628,000 | -3,171,000 | -9,184,000 |
|
Net Income from Continuing Operations
|
38,898,000 | 37,561,000 | 35,853,000 | 26,703,000 | -14,983,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
38,897,000 | 37,561,000 | 35,853,000 | 26,703,000 | -14,983,000 |
|
Non-Controlling/Minority Interests
|
-212,000 | -192,000 | 403,000 | -60,000 | 35,000 |
|
Net Income after Non-Controlling/Minority Interests
|
38,685,000 | 37,369,000 | 36,256,000 | 26,642,000 | -14,948,000 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
-9,000 | -9,000 | -9,000 | -- | -- |
|
Net Income Available to Common Stockholders
|
38,677,000 | 37,361,000 | 36,247,000 | 26,642,000 | -14,948,000 |
|
Dilution to Earnings
|
9,000 | 9,000 | 9,000 | -- | -- |
|
Diluted Net Income Available to Common Stockholders
|
38,685,000 | 37,369,000 | 36,256,000 | 26,642,000 | -14,948,000 |
| Basic EPS
|
119.10 | 114.04 | 103.98 | 72.59 | -38.60 |
| Diluted EPS
|
118.82 | 113.80 | 103.68 | 72.37 | -38.60 |
|
Basic Weighted Average Shares Outstanding
|
323,168.21 | 327,624 | 348,605 | 367,020.25 | 387,253.89 |
|
Diluted Weighted Average Shares Outstanding
|
323,983.72 | 328,374 | 349,694 | 368,135.97 | 387,253.89 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
48,341,000 | 47,797,000 | 46,195,000 | 30,966,000 | -5,453,000 |
|
EBITDA
|
57,235,000 | 56,570,000 | 55,007,000 | 49,144,000 | 11,796,000 |
|
Normalized EBITDA
|
57,235,000 | 56,570,000 | 55,007,000 | 56,923,000 | 46,356,000 |
3/31/2023 - 1/4/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade